These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33259004)

  • 21. Diosgenin ameliorates cellular and molecular changes in multiple sclerosis in C57BL/6 mice.
    Zeinali H; Baluchnejadmojarad T; Roghani M
    Mult Scler Relat Disord; 2021 Oct; 55():103211. PubMed ID: 34425463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathological pain processing in mouse models of multiple sclerosis and spinal cord injury: contribution of plasma membrane calcium ATPase 2 (PMCA2).
    Mirabelli E; Ni L; Li L; Acioglu C; Heary RF; Elkabes S
    J Neuroinflammation; 2019 Nov; 16(1):207. PubMed ID: 31703709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential brain and spinal cord cytokine and BDNF levels in experimental autoimmune encephalomyelitis are modulated by prior and regular exercise.
    Bernardes D; Oliveira-Lima OC; Silva TV; Faraco CC; Leite HR; Juliano MA; Santos DM; Bethea JR; Brambilla R; Orian JM; Arantes RM; Carvalho-Tavares J
    J Neuroimmunol; 2013 Nov; 264(1-2):24-34. PubMed ID: 24054000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats.
    Yin L; Chen Y; Qu Z; Zhang L; Wang Q; Zhang Q; Li L
    J Neuroimmunol; 2014 Sep; 274(1-2):28-37. PubMed ID: 25012120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical analysis of spinal cord components in mouse model of experimental autoimmune encephalomyelitis.
    Pyka-Fosciak G; Stasiolek M; Litwin JA
    Folia Histochem Cytobiol; 2018; 56(3):151-158. PubMed ID: 30187907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
    Vergo S; Craner MJ; Etzensperger R; Attfield K; Friese MA; Newcombe J; Esiri M; Fugger L
    Brain; 2011 Feb; 134(Pt 2):571-84. PubMed ID: 21233144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activating transcription factor 6α deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases.
    Stone S; Wu S; Jamison S; Durose W; Pallais JP; Lin W
    Glia; 2018 Jul; 66(7):1331-1345. PubMed ID: 29436030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of dorsal root ganglia activation and brain-derived neurotrophic factor in multiple sclerosis.
    Zhu W; Frost EE; Begum F; Vora P; Au K; Gong Y; MacNeil B; Pillai P; Namaka M
    J Cell Mol Med; 2012 Aug; 16(8):1856-65. PubMed ID: 22050733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain-derived neurotrophic factor precursor in the immune system is a novel target for treating multiple sclerosis.
    Hu ZL; Luo C; Hurtado PR; Li H; Wang S; Hu B; Xu JM; Liu Y; Feng SQ; Hurtado-Perez E; Chen K; Zhou XF; Li CQ; Dai RP
    Theranostics; 2021; 11(2):715-730. PubMed ID: 33391501
    [No Abstract]   [Full Text] [Related]  

  • 30. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis.
    Aharoni R; Herschkovitz A; Eilam R; Blumberg-Hazan M; Sela M; Bruck W; Arnon R
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11358-63. PubMed ID: 18678887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential Expression of Klotho in the Brain and Spinal Cord is Associated with Total Antioxidant Capacity in Mice with Experimental Autoimmune Encephalomyelitis.
    Emami Aleagha MS; Harirchian MH; Lavasani S; Javan M; Allameh A
    J Mol Neurosci; 2018 Apr; 64(4):543-550. PubMed ID: 29542092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE).
    Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaei M; Keyvani H
    Int Immunopharmacol; 2020 Jan; 78():105943. PubMed ID: 31830622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [
    Hoehne A; James ML; Alam IS; Ronald JA; Schneider B; D'Souza A; Witney TH; Andrews LE; Cropper HC; Behera D; Gowrishankar G; Ding Z; Wyss-Coray T; Chin FT; Biswal S; Gambhir SS
    J Neuroinflammation; 2018 Feb; 15(1):55. PubMed ID: 29471880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG
    Kamali S; Rajendran R; Stadelmann C; Karnati S; Rajendran V; Giraldo-Velasquez M; Berghoff M
    Brain Pathol; 2021 Mar; 31(2):297-311. PubMed ID: 33103299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation.
    Valentin-Torres A; Savarin C; Barnett J; Bergmann CC
    J Neuroinflammation; 2018 Apr; 15(1):121. PubMed ID: 29690885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
    Kumar S; Patel R; Moore S; Crawford DK; Suwanna N; Mangiardi M; Tiwari-Woodruff SK
    Neurobiol Dis; 2013 Aug; 56():131-44. PubMed ID: 23603111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia.
    Bannerman P; Hahn A; Soulika A; Gallo V; Pleasure D
    Glia; 2007 Jan; 55(1):57-64. PubMed ID: 17009237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune Encephalomyelitis.
    Rajendran R; Rajendran V; Gupta L; Shirvanchi K; Schunin D; Karnati S; Giraldo-Velásquez M; Berghoff M
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models.
    Cheng A; Jia W; Kawahata I; Fukunaga K
    EBioMedicine; 2021 Oct; 72():103582. PubMed ID: 34624687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NF-κB Activation Accounts for the Cytoprotective Effects of PERK Activation on Oligodendrocytes during EAE.
    Lei Z; Yue Y; Stone S; Wu S; Lin W
    J Neurosci; 2020 Aug; 40(33):6444-6456. PubMed ID: 32661025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.